Charged Alpha logo
CHARGED ALPHA
Stock Analysis
UHS Healthcare Latest YouTube: Q1 2026 Published 2026-04-28

Universal Health Services, Inc.

Live stock metrics, chart context, a quarter-by-quarter episode archive, and a deeper competitor comparison so this page behaves more like an investor workspace than a flat episode link page.

Latest earnings video

UHS Stock: EPS Beats by 12% — Q1 2026 Earnings Analysis

Published 2026-04-28

Library coverage

Episodes tracked
1
Episodes linked
1
Latest video
Q1 2026
2026-04-28
Podcast available
Yes
Current price
$177.26
+2.01 (+1.15%)
Trailing / Forward P/E
7.24x
Forward: 7.38x
Market cap / Volume
Volume:
Revenue / Earnings Growth
8.3%
Earnings: 10.1%
Margins
11.1% op
Gross: 44.6% · Net: 8.4%
Balance sheet
1.12x current
Debt / Equity: 68.7
52-week range / Beta
$140.08 - $246.33
Beta: 1.06
Analyst target
$193.94
Upside: 9.4%
Cash / shareholder return
4.77% FCF yield
Dividend yield: 0.46%

Company context

Industry: Medical Care Facilities
Country: United States
Employees:
Price to book: 1.39x
Return on equity: 20.9%
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities in the United States. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric, pharmacy, and/or behavioral health services. It also provides commercial health insurance services; capital resources; and various management services, including central purchasing, information services, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. was founded in 1978 and is headquartered in King of Prussia, Pennsylvania.

Price chart

Market context for UHS

Competitive view

UHS vs. two close competitors

This section compares the current company against two nearby peers on valuation, growth, margins, balance-sheet strength, and investment setup. Green generally marks the strongest relative figure for that row, while red marks the weakest.

Universal Health Services, Inc. latest YouTube video thumbnail YouTube
Universal Health Services, Inc.
UHS
Latest video
Q1 2026
Growth is positive but not explosive, which usually supports a steadier compounding case than a hyper-growth story.
Cash generation stands out versus market value, which helps the stock absorb valuation pressure better than weaker cash converters.
Valuation looks more grounded than many growth names, which can improve the risk/reward if fundamentals hold up.
Risk profile looks relatively manageable compared with many peers, especially if operating execution remains stable.
Intuitive Surgical latest YouTube video thumbnail YouTube
Intuitive Surgical
ISRG
Latest video
Q2 2026
Growth profile looks strong right now, with above-average top-line and/or earnings momentum.
Profitability is a real strength here, with healthy operating margins helping support resilience through weaker cycles.
Valuation already asks investors to pay up, so the upside case depends on continued execution staying strong.
Risk profile looks relatively manageable compared with many peers, especially if operating execution remains stable.
Johnson & Johnson latest YouTube video thumbnail YouTube
Johnson & Johnson
JNJ
Latest video
Q2 2026
Growth is positive but not explosive, which usually supports a steadier compounding case than a hyper-growth story.
Profitability is serviceable, but it does not obviously dominate peers on margin or cash conversion alone.
Valuation sits in a middle zone where future upside likely depends more on quarterly execution than on multiple re-rating alone.
Risk profile looks relatively manageable compared with many peers, especially if operating execution remains stable.
Market Cap
More scale can mean deeper resources and resilience, although bigger does not automatically mean better upside.
UHS
$10.45B
Universal Health Services, Inc.
ISRG
$135.72B
Intuitive Surgical
JNJ
$651.25B
Johnson & Johnson
Trailing P/E
Lower trailing P/E can indicate a cheaper valuation relative to trailing earnings, but it may also reflect slower growth or higher perceived risk.
UHS
7.2x
Universal Health Services, Inc.
ISRG
43.5x
Intuitive Surgical
JNJ
31.4x
Johnson & Johnson
Forward P/E
Forward P/E is often a better read on what investors are paying for the next year of earnings power.
UHS
7.4x
Universal Health Services, Inc.
ISRG
31.4x
Intuitive Surgical
JNJ
22.0x
Johnson & Johnson
Revenue Growth
Higher revenue growth usually signals stronger demand, market share gains, or a business still in expansion mode.
UHS
8.3%
Universal Health Services, Inc.
ISRG
18.5%
Intuitive Surgical
JNJ
6.6%
Johnson & Johnson
Earnings Growth
Faster earnings growth matters because it shows management is converting sales momentum into shareholder value.
UHS
10.1%
Universal Health Services, Inc.
ISRG
26.5%
Intuitive Surgical
JNJ
-0.9%
Johnson & Johnson
Operating Margin
Higher operating margin suggests better operating discipline, pricing power, or a structurally stronger business model.
UHS
11.1%
Universal Health Services, Inc.
ISRG
33.6%
Intuitive Surgical
JNJ
29.2%
Johnson & Johnson
Gross Margin
Gross margin helps show how much product-level pricing power and unit economics a company has before overhead.
UHS
44.6%
Universal Health Services, Inc.
ISRG
66.7%
Intuitive Surgical
JNJ
68.1%
Johnson & Johnson
Net Margin
Higher net margin means more of each dollar of revenue reaches the bottom line after all costs.
UHS
8.4%
Universal Health Services, Inc.
ISRG
28.4%
Intuitive Surgical
JNJ
21.5%
Johnson & Johnson
Return on Equity
ROE shows how efficiently management turns shareholder capital into profits, though leverage can inflate it.
UHS
20.9%
Universal Health Services, Inc.
ISRG
17.4%
Intuitive Surgical
JNJ
25.7%
Johnson & Johnson
Free Cash Flow Yield
Higher free cash flow yield can indicate a stronger cash return relative to the stock's market value.
UHS
4.8%
Universal Health Services, Inc.
ISRG
1.9%
Intuitive Surgical
JNJ
2.6%
Johnson & Johnson
Debt to Equity
Lower leverage usually means less balance-sheet risk, though capital-intensive sectors naturally run higher debt loads.
UHS
68.74x
Universal Health Services, Inc.
ISRG
Intuitive Surgical
JNJ
57.71x
Johnson & Johnson
Current Ratio
A stronger current ratio usually signals better short-term liquidity and more room to absorb shocks.
UHS
1.12x
Universal Health Services, Inc.
ISRG
4.96x
Intuitive Surgical
JNJ
1.09x
Johnson & Johnson
Beta
Lower beta often means lower volatility versus the market, while higher beta usually brings a rougher ride.
UHS
1.06
Universal Health Services, Inc.
ISRG
1.46
Intuitive Surgical
JNJ
0.23
Johnson & Johnson
Dividend Yield
Dividend yield matters for income-focused investors, but a high yield can also reflect a stressed stock price.
UHS
0.5%
Universal Health Services, Inc.
ISRG
Intuitive Surgical
JNJ
2.0%
Johnson & Johnson
Analyst Upside
Higher analyst upside suggests the Street still sees room between current price and consensus fair value.
UHS
9.4%
Universal Health Services, Inc.
ISRG
26.2%
Intuitive Surgical
JNJ
0.8%
Johnson & Johnson

Episode timeline

Episode archive for UHS

Each row is one earnings episode with every verified platform link available.

Q1 2026
Episode live
2026-04-28
Published youtube podcast complete
UHS Stock: EPS Beats by 12% — Q1 2026 Earnings Analysis
Quarterly earnings-analysis entry for Universal Health Services, Inc.. Use the links on the right to open the video or podcast episode.